# US 2014/0350662 A1 · Device for placement in the tricuspid annulus

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2014/0350662 A1
- Document ID: US20140350662A1
- Status: Published application
- Kind: A1
- Application number: 14/359,646
- Filed: 2012-11-21
- Published: 2014-11-27
- Earliest claimed: 2011-11-21
- Assignees: Mor Research Applications Ltd.
- Applicants: Mor Research Applications Ltd.
- Inventors: Mordehay Vaturi
- Web page: https://patentgrep.com/patent/US20140350662A1

## CPC

- A61F 2/2445: {Annuloplasty rings in direct contact with the valve annulus}
- A61F 2/2409: {Support rings therefor, e.g. for connecting valves to tissue (annuloplasty rings A61F2/2442)}
- A61F 2/2412: {with soft flexible valve members, e.g. tissue valves shaped like natural valves}
- A61F 2/2454: {Means for preventing inversion of the valve leaflets, e.g. chordae tendineae prostheses}
- A61F 2/246: {Devices for obstructing a leak through a native valve in a closed condition}
- A61F 2/2463: {Implants forming part of the valve leaflets}
- A61F: FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS (dental prosthetics A61C)

## Abstract

A device (200) for implantation in or near an annulus of a tricuspid valve comprising at least one blood flow control element (202) adapted to capture a volume of blood therein. Optionally or alternatively, the blood flow control element is adapted to allow at least some volume of blood (406) to regurgitate through the annulus during at least some part of systole. Optionally or alternatively, the device comprises a relatively rigid annulus with an arc length of less than 300 degrees. Optionally or alternatively, the relatively rigid annulus comprises a plurality of tissue fixation elements positioned along no more than 300 degrees of a circumference of the annulus, for example to avoid damaging conduction pathways between an atria and a chamber.

## Claims

### Claim 1

A device for implantation at or near an annulus of a tricuspid valve comprising at least one blood flow control element adapted to capture a volume of blood therein, wherein the volume of blood is held by said at least one blood flow control element in an atrium;
wherein said device is configured to be anchored to at least a portion of the tricuspid annulus.

### Claim at position 2

2-4. (canceled)

### Claim 5 (depends on 1)

A device according to claim 1, wherein said blood flow control element is a sail.

### Claim 6 (depends on 1)

A device according to claim 1, wherein said volume of blood is between 5 and 20 ml.

### Claim 7

(canceled)

### Claim 8 (depends on 1)

A device according to claim 1, wherein said volume of blood is at least 8 mL.

### Claim 9 (depends on 1)

A device according to claim 1, wherein said device is adapted for allowing at least some blood to regurgitate through said annulus during systole, wherein said at least some blood is between 3 and 25 mL.

### Claim 10

(canceled)

### Claim 11 (depends on 9)

A device as in claim 9, wherein said device is adapted for allowing at least some blood to regurgitate through said annulus during systole, and wherein a total area for said blood regurgitation is no more than 20 mm 2.

### Claim at position 10

12-15. (canceled)

### Claim 16 (depends on 1)

A device according to claim 1, wherein said device comprises one or more members adapted to retain most of said blood flow control element in an atrial aspect of said device during diastole.

### Claim at position 12

17-18. (canceled)

### Claim 19 (depends on 1)

A device as in claim 1, wherein said size of said device is sufficiently short to preserve function of a septal leaflet.

### Claim at position 14

20-21. (canceled)

### Claim 22 (depends on 1)

A device according to claim 1, further comprising a support element adapted to contact at least a portion of said annulus, said element coupled to said support element, wherein said support element has an incomplete circumference of between 180 and 300 degrees.

### Claim at position 16

23-24. (canceled)

### Claim 25 (depends on 22)

A device according to claim 22, wherein said blood flow control element spans at least 90% of said incomplete circumference.

### Claim 26 (depends on 22)

A device according to claim 22, wherein said support element is radially expandable.

### Claim 27 (depends on 1)

A device according to claim 1, wherein said device comprises a plurality of tissue fixation elements, said tissue fixation elements located along no more than 270 degrees along a circumference of said device, leaving a gap of at least 7 mm.

### Claim 28 (depends on 27)

A device as in claim 27, wherein at least some of said tissue fixation elements are positioned to fixate to at least one of a ventricular aspect of said annulus and an atrial aspect of said annulus.

### Claim 29

(canceled)

### Claim 30 (depends on 22)

A device according to claim 22, wherein said support element has a non-symmetrical shape and said support element is adapted to have an open contiguous area of at least 1 cm2, said contiguous area is adapted to be placed towards a coronary sinus.

### Claim 31 (depends on 1)

A device according to claim 1, wherein said device is sized to maintain a gap of at least 3 mm between said blood flow control element and at least one remaining functional tricuspid leaflet, said gap along at least 50% of a length of said leaflet.

### Claim 32 (depends on 1)

A device according to claim 1, wherein said device is configured for replacing at least one leaflet of a tricuspid valve, said device further comprising:
a relatively rigid support, said support having an arc length of between 180 degrees and 300 degrees;
wherein said at least one blood flow control element is configured for controlling flow, said element coupled to said rigid support, wherein said element resists flow less for flow from the atrium than for flow from the ventricle.

### Claim 33 (depends on 1)

A device according to claim 1, said device configured for replacing a tricuspid valve, said device further comprising:
a relatively rigid support, said support comprising a plurality of tissue fixation elements adapted to pierce tissue or otherwise interfere with conduction in-fixed to tissue, positioned along no more than 300 degrees of a circumference thereof; and
a prosthetic valve or part thereof coupled to said support.

### Claim 34 (depends on 38)

A method according to claim 38, said deploying including deploying in an annulus of a tricuspid valve, said method further comprising expanding said device without said device contacting a membranous septum when in an implanted state.

### Claim 35 (depends on 38)

A method as in claim 38, wherein said device is deployed without contacting at least one of an atrioventricular node and a bundle of His.

### Claim at position 28

36-37. (canceled)

### Claim 38

A method of treating tricuspid regurgitation comprising percutaneously deploying a device, said device comprises a blood flow control element adapted to temporarily store blood from the ventricle in an atrium, in said element, and/or allow a reduced amount of regurgitation through or past the device, in a tricuspid annulus of a subject in need of treatment thereof;
wherein said device is con anchored to at least a portion of the tricuspid annulus.

### Claim 39 (depends on 38)

A method according to claim 38, comprising selecting said device to reduce an amount of regurgitated blood by 30%-80%, thereby treating said regurgitation.

### Claim 40 (depends on 38)

A method according to claim 38, comprising selecting said device to temporarily capture at least 50% of regurgitated blood, thereby treating said regurgitation.

### Claim at position 32

41-42. (canceled)

### Claim 43

A device for implantation in the annulus of a tricuspid valve comprising at least one blood flow element adapted to allow a volume of blood to regurgitate through said annulus during at least some part of a systole;
wherein said device is configured to be anchored to at least a portion of the tricuspid annulus.

### Claim 44 (depends on 38)

A method according to claim 38, said device configured for:
capturing at least some volume of regurgitated blood in said blood flow control element during at least some part of systole; and
releasing at least some volume of said captured blood into a right ventricle during at least some part of diastole.

### Claim 45 (depends on 43)

A device according to claim 43, wherein the volume is at least 3 mL.
